Medical News

RSS

InfraReDx to demonstrate LipiScan coronary imaging system during CCC Symposium

InfraReDx, Inc., an innovative medical device company focused on developing novel diagnostic imaging technologies to accurately identify and characterize diseased tissues, today announced that its LipiScan Coronary Imaging System will be featured at the 13th Annual Live Symposium of Complex Coronary & Vascular Cases being held at The Mount Sinai Medical Center of New York, from June 16-19, 2010.

16 Jun 2010

Lantis Laser to merge with Perio-Imaging

Lantis Laser Inc., announced today that it has signed a Letter of Intent to merge with Perio-Imaging Inc., a private New York based company. The merger would be an all stock transaction and closing, among other conditions, would be subject to raising the required funding to complete the proposed merged company's product development program. The name of the new merged company will be announced upon closing.

16 Jun 2010

Phase 3 U.S. registration study of LODOTRA shows improvement in patients with RA

Horizon Pharma, Inc., announced today that data from the Phase 3 U.S. registration study of LODOTRA, a circadian cytokine modulator and novel modified-release, low-dose prednisone tablet, showed a statistically significant improvement in American College of Rheumatology response criteria in patients with rheumatoid arthritis.

16 Jun 2010

GTC Biotherapeutics closes new $7 million secured convertible debt financing

GTC Biotherapeutics, Inc. announced the closing of a new $7 million secured convertible debt financing by its strategic partner, LFB Biotechnologies SAS, in connection with a restructuring of GTC's operations which will result in a downsizing of approximately 30 full-time positions at its headquarters and an additional 20 positions at its farm facility.

16 Jun 2010

Brazilian breast cancer drug market to grow from $424M in 2009 to $611M in 2014: Decision Resources

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the breast cancer drug market in Brazil will grow from $424 million in 2009 to $611 million in 2014. Factors promoting the market's growth include steady increases in the number of incident breast cancer cases, shifts toward higher-cost chemotherapy and hormonal regimens in the adjuvant setting and increases in the use of targeted therapies following novel product launches and label extensions.

16 Jun 2010

RG7204 holds promise for metastatic melanoma with V600E BRAF mutation

Preclinical findings recently published in Cancer Research, a journal of the American Association for Cancer Research, showed RG7204 (PLX4032) inhibited proliferation of tumor cell lines that expressed V600E-BRAF, a mutation found in several human cancers, including melanoma.

16 Jun 2010

CAMFT listed in 2010 Associations Advance America Honor Roll

The California Association of Marriage and Family Therapists has been named to the 2010 Associations Advance America Honor Roll, a national awards competition sponsored by the American Society of Association Executives & The Center for Association Leadership, Washington, D.C.

16 Jun 2010

AssureImmune merges with BCU

AssureImmune LLC, the premier family stem cell bank in the United States, today announced their merger with Banco de Cordón Umbilical, the largest cord blood bank in Latin America. This merger expands the Companies' global reach providing family stem cell banking services to North, Central and South America.

16 Jun 2010

Stress-related psychiatric disorders more common among women: Study

There may be a biological reason why depression and other stress-related psychiatric disorders are more common among women compared to men. Studying stress signaling systems in animal brains, neuroscience researchers found that females are more sensitive to low levels of an important stress hormone and less able to adapt to high levels than males.

16 Jun 2010

Life Technologies forms GIBCO Cell Therapy Systems

Life Technologies Corporation today announced the formation of GIBCO® Cell Therapy Systems (CTS™), which will offer the life science industry's widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from research to clinical applications, the product portfolio will include a broad and deep offering of Invitrogen devices and reagents.

16 Jun 2010

MainStreet Monitoring Devices announces cause marketing partnership with Special Olympics Massachusetts

MainStreet Monitoring Devices, Inc., an innovator of superior personal safety, telemedicine and wireless health solutions to advance the care and protection of children and seniors, today announces its marketing partnership with Special Olympics Massachusetts on the eve of the 2010 Summer Games. MainStreet MD will donate a portion of its proceeds in support of more than 2200 Special Olympics athletes expected to compete in the Summer Games scheduled June 18-20, at Harvard University.

16 Jun 2010

Geochemists discuss new ways to tackle problems associated with greenhouse gas

As carbon dioxide levels in the atmosphere rise, policy makers and scientists are looking at new ways to tackle the problems associated with the greenhouse gas. One method under much discussion is carbon capture and storage, otherwise known as carbon sequestration. CCS, a newly developing technology, involves injecting carbon dioxide underground to remove it from the Earth's atmosphere.

16 Jun 2010

Phase IIb EMBLEM study demonstrates clinical efficacy of epratuzumab in patients with SLE

UCB and Immunomedics Inc. announced new lupus drug candidate, epratuzumab, provided a significant reduction in disease activity in patients with moderate to severe active systemic lupus erythematosus (SLE). Data presented at the European League Against Rheumatism (EULAR) meeting in Rome from the phase IIb study, EMBLEM™, showed the clinical efficacy of epratuzumab in patients with SLE.

16 Jun 2010

SOA provides clarity regarding law's consequences on existing health insurance plans, benefits

With the approaching national implementation of The Mental Health Parity and Addiction Equity Act on July 1, 2010, members of the Society of Actuaries are providing clarity regarding the law's potential unintended consequences on consumers' existing health insurance plans and benefits. While the law is intended to provide non-discriminatory mental health coverage, members of the SOA are helping consumers and large and small employers understand what effects the law will have on current health plan offerings, and what individuals can do to help avoid higher out-of-pocket costs.

16 Jun 2010

First annual International Iridoid Research Symposium to be held in Provo, Utah

Tahitian Noni International announced that the first annual International Iridoid Research Symposium will be held at TNI headquarters in Provo, Utah, on August 16th and 17th. Scientists from around the world will be presenting current research on iridoids in both plants and animals. The symposium is being presented by the International Iridoid Research Council, which is a new organization dedicated to the sharing of information and research being conducted on iridoids.

16 Jun 2010

Hamilton Thorne announces launch of Staccato multi-pulse laser system at 8th ISSCR Annual Meeting

Hamilton Thorne Ltd., a leading provider of advanced laser systems and instruments for the stem cell research and fertility clinic markets, today announced the launch of the Staccato(TM) multi-pulse laser system at the 8th Annual Meeting of the International Society of Stem Cell Research (ISSCR), June 16-19, 2010, in San Francisco, CA. Staccato(TM) will add to the functionality of the XYClone(R) laser system, providing the ability of near-continuous application of the laser to the sample through rapid pulsing of the beam.

16 Jun 2010

VIVUS to present data on Qnexa at ENDO meeting

VIVUS, Inc. today announced that data on Qnexa, an investigational drug candidate, will be presented at the Endocrine Society's 92nd Annual Meeting and Expo in San Diego, California. Timothy Garvey, M.D., professor of medicine and chair of the department of nutrition sciences at the University of Alabama at Birmingham and a Qnexa investigator, will deliver an oral presentation at the Clinical Trials Symposium on Saturday, June 19, entitled: "Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate Demonstrates Significant Improvement in Weight, Related Risk in Overweight/Obese Patients with Comorbidities."

16 Jun 2010

Nuon Therapeutics NU1618 phase 2a study in hyperuricemia meets primary endpoint

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that a phase 2a study of NU1618, the company's lead program, met its primary endpoint of reduction in serum uric acid (sUA) levels in patients with hyperuricemia.

16 Jun 2010

Alameda Alliance for Health utilizes MedeAnalytics' analytic solutions to improve member outcomes, services

MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Alameda Alliance for Health, based in Alameda, Calif., has selected MedeAnalytics' Provider Network Management Analytics and Medical Management Analytics solutions. The Alliance will utilize these analytic solutions to improve member outcomes and services.

16 Jun 2010

Predictive Biosciences completes $25M Series C financing round

Predictive Biosciences, a commercial stage, fully-integrated developer of novel molecular diagnostic cancer assays and a provider of anatomic pathology laboratory products and services, today announced the completion of a $25 million Series C round of growth capital financing. New investor ProQuest Investments led the round, joined by all current investors: Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates.

16 Jun 2010

Medical News

InfraReDx to demonstrate LipiScan coronary imaging system during CCC Symposium

Lantis Laser to merge with Perio-Imaging

Phase 3 U.S. registration study of LODOTRA shows improvement in patients with RA

GTC Biotherapeutics closes new $7 million secured convertible debt financing

Brazilian breast cancer drug market to grow from $424M in 2009 to $611M in 2014: Decision Resources

RG7204 holds promise for metastatic melanoma with V600E BRAF mutation

CAMFT listed in 2010 Associations Advance America Honor Roll

AssureImmune merges with BCU

Stress-related psychiatric disorders more common among women: Study

Life Technologies forms GIBCO Cell Therapy Systems

MainStreet Monitoring Devices announces cause marketing partnership with Special Olympics Massachusetts

Geochemists discuss new ways to tackle problems associated with greenhouse gas

Phase IIb EMBLEM study demonstrates clinical efficacy of epratuzumab in patients with SLE

SOA provides clarity regarding law's consequences on existing health insurance plans, benefits

First annual International Iridoid Research Symposium to be held in Provo, Utah

Hamilton Thorne announces launch of Staccato multi-pulse laser system at 8th ISSCR Annual Meeting

VIVUS to present data on Qnexa at ENDO meeting

Nuon Therapeutics NU1618 phase 2a study in hyperuricemia meets primary endpoint

Alameda Alliance for Health utilizes MedeAnalytics' analytic solutions to improve member outcomes, services

Predictive Biosciences completes $25M Series C financing round

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News